The Treatment of Vascular Access Graft Dysfunction: A Nephrologist's View And Experience

Advances in Renal Replacement Therapy

Volumn 1, Issue 2, 1994, Pages 131-147

  Beathard, Gerald A ^a  

^a Austin Diagnostic Clinic   (United States)

Author keywords

angioplasty; Hemodialysis; PTA; thrombolysis; vascular access

Indexed keywords

ANGIOPLASTY; BLOOD VESSEL PROSTHESIS; FIBRINOLYTIC THERAPY; HEMODIALYSIS; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; METHODOLOGY; NEPHROLOGY; PROSTHESIS FAILURE; REVIEW; STENT; VASCULAR SURGERY;

ANGIOPLASTY; BLOOD VESSEL PROSTHESIS; CATHETERS, INDWELLING; HUMAN; NEPHROLOGY; PROSTHESIS FAILURE; RENAL DIALYSIS; STENTS; THROMBOLYTIC THERAPY; VASCULAR SURGICAL PROCEDURES;

EID: 0028477562     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1073-4449(12)80044-6     Document Type: Article

References (67)

1. Expanded polytetrafluoroethylene (PTFE) subcutaneous arteriovenous conduit: an improved vascular access for chronic hemodialysis
2. Permanent vascular access: A nephrologist's view
3. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula
4. Nine years' experience with internal arteriovenous fistulas for haemodialysis: A study of some factors influencing the results
5. Prospective study of dialysis fistulas: Problem patients and their treatment
6. A prospective study of end-to-side vs. side-to-side arteriovenous fistulas for hemodialysis
7. Vascular access: Experience with the brachiocephalic fistula
8. Vascular access for hemodialysis
9. Hemodialysis vascular access
10. What can be done to preserve vascular access for dialysis?
11. Expanded polytetrafluorethylene graft fistula for chronic hemodialysis
12. Experience with one hundred reinforced expanded PTFE grafts for angio-access in hemodialysis
13. Polytetrafluoroethylene graft survival in hemodialysis
14. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis
15. What can be done to preserve vascular access for dialysis?
16. Vascular access morbidity in the US
17. PTFE grafts for hemodialysis access: Techniques for insertion and management of complications
18. Salvage operations for malfunctioning polytetrafluoroethylene hemodialysis grafts
19. Pulse-spray pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts
20. Mechanical vs pharmacomechanical thrombolysis for clotted dialysis access grafts
21. Hemodialysis fistula thromboses: A prospective evaluation of anatomic versus nonanatomic causes
22. What can be done to preserve vascular access for dialysis
23. Prevention of hemodialysis fistula thrombosis. Early detection of venous stenosis
24. A prophylactic approach to graft thrombosis is not yet justifiable
25. Management of dialysis fistula thrombosis
26. Midgraft curettage as a routine adjunct to salvage operation for thrombosed polytetrafluoroethylene hemodialysis access grafts
27. Complications of renal dialysis access procedures
28. Thrombosed polytetrafluoroethylene hemodialysis fistulas: Salvage with combined thrombectomy and angioplasty
29. Hemodialysis associated subclavian vein stenosis
30. Proximal vein thrombosis secondary to hemodialysis catheterization complicated by arteriovenous fistula
31. Outpatient vascular access surgery: Impact of a dialysis unit-based surgical facility
32. Vascular access surgery for maintenance hemodialysis: Variables in hospital stay
33. Transluminal angioplasty of venous stenoses in polytetrafluoroethylene vascular access grafts
34. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis
35. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas
36. Physical examination of AV grafts
37. Total central vein obstruction: Resolution with angioplasty and fibrinolysis
38. Dialysis access: Radiographic evaluation and management
39. Mechanisms of angioplasty in hemodialysis fistula stenoses evaluated by intravascular ultrasound
40. Insufficient hemodialysis access fistulas: Late results of treatment with percutaneous balloon angioplasty
41. Forecasting thrombosis of vascular access with Doppler color flow imaging
42. Use of the fistula assessment monitor to detect stenoses in access fistulae
43. Endovascular stenting of veins and grafts: Preliminary clinical experience
44. Venous stenosis in dialysis shunts: Treatment with self-expanding metallic stents
45. Venous stenoses in patients who undergo hemodialysis; Treatment with self-expandable endovascular stents
46. Balloon expandable stents to treat central venous stenoses in hemodialysis patients
47. Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts
48. Treatment of central venous stenoses: Role of transluminal angioplasty (PTA) and endovascular Wall stents
49. The use of urokinase in Scribner shunts
50. Clearing of clotted dialysis shunts by streptokinase injection at multiple sites
51. Low dose streptokinase therapy for thrombosed arteriovenous fistulas
52. Urokinase treatment for arteriovenous fistulae declotting in dialyzed patients
53. Thrombosed Synthetic hemodialysis fistulas: Failure of fibrinolytic therapy
54. Arterial and venous embolization: declotting of dialysis shunts by direct injection of streptokinase
55. Successful declotting of arteriovenous grafts with local infusion of urokinase in hemodialysed patients
56. The role of thrombolysis in hemodialysis access occlusion
57. Efficacy of thrombolysis of thrombosed dialysis accesses with urokinase
58. Pulsed-spray pharmacomechanical thrombolysis: Preliminary clinical results
59. Pharmacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: Early and late results
60. “How I do it”: Pulse-spray pharmacomechanical thrombolysis
61. The use of tissue plasminogen activator to declot arteriovenous accesses in hemodialysis patients
62. Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts: A controlled study
63. Thrombolysis of peripheral arterial and graft occlusions: Improved results using high-dose urokinase
64. Accelerated thrombolysis: In vitro evaluation of agents and methods of administration
65. Thrombosed dialysis grafts: Efficacy of intrathrombic deposition of concentrated urokinase, clot maceration and angioplasty
66. Failing arteriovenous dialysis fistulas: Evaluation and treatment
67. Thrombosed dialysis access grafts: Percutaneous declotting without urokinase